可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Mancia G.Sympathetic activation in congestive heart failure[J].Eur Heart J,1990,11(supplA),3.
[2]Kats SD. The role of eadothellum derived vasoactive substances in the pathophysiology of exercise intderauce in patiauts with CHF[J].Prog Cardiovasc Dis,1995,38(1),23.
[3] Riegger AJG.Neuroendocrine excitation in heart failure[J].Br Heart J,1994,72(suppIA):28.
[4]罗亲新,陈运贞.动态血压监测在评价高血压病靶器官损害中的预测价值[J].心血管病学进展.1998,19(2):69.
[5]张风如,张维忠,顾刚,等.充血性心力衰竭的昼夜动态血压特征及临床意义[J].高血压杂志,1999,7(3):246.
[6]Giles TD,Roffidal L,Quiroz A,et al.Circadian variation in b1ood pressure and heart rate in non-hypertensive congestive heart failure[J].J Cardial Pharmacol,1996,28(11):733.
[7]Thomas JA,Marks BH.Plasma norepinephrine in congestive heart failure[J].Am J Cardiol.1998,41(3):233.
[8]方圻.β受体阻断剂用于充血性心力衰竭的治疗[J].中华心血管病杂志,1999,27(6),472.
[9] Jougasaki M,Rodeheffer RJ. Carrdiac secreuon of adrenomedullin in human heart failure[J].J Clin Invest,1996.97(24):2370.